Although the improved water solubility of the glycosides did not cause superior anticancer and antiangiogenic activities to α-mangostin against HCC cells in vitro, the analogs effectively suppressed the growth, migration, and tumor angiogenesis of HCC cells through the blockade of c-Met signaling and HIF-1α expression. The gene discussed is MET; the disease is hepatocellular carcinoma.